Objectives: This study aims to figure out more accurate staging and proper therapeutic strategy for carcinoma of external auditory canal and middle ear. Study Design: Retrospective review of medical records of patients who were diagnosed as squamous cell carcinoma or adenoid cystic carcinoma of external auditory canal and middle ear between 1989 and 2006.
INTRODUCTION
Carcinoma of the external auditory canal and middle ear is a rare disease with a prevalence of 1-6/1,000,000/year. Treatment of the carcinoma was first reported in 1890, and the technical innovation of en bloc resection was accomplished since 1950s3. However, treatment is still very difficult and prognosis remains poor, because of the rare incidence, which leads to limited experience, late diagnosis and no coherent staging system of the tumor.
Staging systems for the carcinoma of the external auditory canal and middle ear have been described in many literatures, but, unfortunately, there are no universal one. For example, facial nerve invasion is categorized into T4 in modified Pittsburg staging system , which is most commonly used recently, but it is classified as stage III, not N, in the Otology group classification and is categorized into T2 in the classification of Clark et al. Also, temporomandibular joint invasion is classified as T4, stage II and T3 in modified Pittsburg staging system, Otology group classification and the classification of Clark et a1, respectively. One can find that parotid gland invasion is also classified into different stages in each staging system (Table 1) .
A number of studies have suggested different treatment methods of the carcinoma, but conclusion to date is that the best results can be obtained with en bloc resection of the tumor together with radiotherapy'". However, there are no universally acceptable staging systems which means the surgical extent can be different depending on which system was used. Adjuvant radiotherapy has been reported to improve the survival of the patients but, in some reports, it was described that radiotherapy did not benefit those with incomplete tumor resection . In this study, we investigated the treatment outcomes of the tumor according to pathologies, modified Pittsburg staging system and surgical extent. The correlation between treatment outcomes and invasion to adjacent structures of those, which were differently described in many staging systems were also investigated.
Finally, we investigated the effectiveness of adjuvant radiotherapy in the tumors of advanced stages and propose some complementary points on staging system and treatment of the external auditory canal and middle ear carcinoma.
PATIENTS AND METHODS
Patients 34 patients (15 males, 19 females, mean age 54 years, range 29-77 years) whose histopathology were reported to be squamous cell carcinoma (SCC) or adenoid cystic carcinoma (ACC) were Table 1 Current status of staging system 
RESULTS

Treatment outcomes according to pathologies and stages
The estimated disease-free five-year survival rates were 52.7% overall , and 36.1% for SCC and 71.8% for ACC respectively (Fig. 2 Fig. 5 ). There was no significant difference in survival rate between the two groups (p > 0.05). We could not find any difference in survival rate between the two groups when we compared them in the aspect of two different pathologies . (Fig. 6 
